📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
3 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
211
ANNX Latest News & AI Sentiment Analysis
3 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 7 ARTICLES
Annexon outlines Q4 BLA filing for tanruprubart while adding month 24 dual primary endpoint to ARCHER II (NASDAQ:ANNX)
Annexon (ANNX) disclosed routine clinical trial milestones during its Q2 2026 earnings call, including plans to file a Biologics License...
Annexon, Inc. (ANNX) Q2 2026 Earnings Call Transcript
ANNX released its Q2 2026 earnings call transcript on August 12, 2026. As a procedural disclosure of scheduled earnings communication,...
Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
Annexon Pharmaceuticals (ANNX) disclosed Q2 2026 financial results alongside clinical and operational updates for its lead candidate...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Annexon (ANNX) announced routine equity inducement grants to two new non-executive employees under its 2022 Employment Inducement Award...
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data
APLM's 22% gain reflects a technical relief rally following Nasdaq compliance restoration rather than fundamental clinical advancement....
Annexon: Perfect Complement To A Speculative Biotech Portfolio (NASDAQ:ANNX)
ANNX is positioned as a speculative biotech play with near-term clinical catalysts, particularly centered on tanruprubart for...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Annexon Inc. (ANNX) disclosed routine equity compensation grants to two new non-executive employees under its 2022 Employment Inducement...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice